Vivodyne
Latest round
- Series A
Last raised
- May 2025
Total raised
- $80M
Investors
- 8
About Vivodyne
, provides platform technology that permits independently lab-grown, living portions of human organs to test direct drug and life-saving biologic testing on these realistic human tissues. In May 2025, Vivodyne, Inc., Kairos Ventures and MBX Capital.
Who invested in Vivodyne
8 investors across 3 rounds
See all investors in Vivodyne
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vivodyne
Who invested in Vivodyne?
Vivodyne has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vivodyne raised?
Vivodyne has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Vivodyne last raise money?
Vivodyne's most recent round on record is a Series A, in May 2025.
What does Vivodyne do?
, provides platform technology that permits independently lab-grown, living portions of human organs to test direct drug and life-saving biologic testing on these realistic human tissues.
Where is Vivodyne headquartered?
Vivodyne is headquartered in San Francisco, US.
Which VCs invest in companies like Vivodyne?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vivodyne's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vivodyne? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.